JAMA Otolaryngology–Head & Neck Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 18, 2023
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2023.0949?guestAccessKey=1fb6f0b4-4c34-4f90-9ff0-fd98e440f949&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051823
About The Study: In this cost-effectiveness analysis, provision of over-the-counter (OTC) hearing aids was associated with greater uptake of hearing intervention and was cost-effective over a range of prices so long as OTC hearing aids were greater than 55% as beneficial to patient quality of life as traditional hearing aids. Over-the-counter hearing aids may expand access to beneficial treatment for hearing loss and represent an efficient use of resources.
Authors: Gillian D. Sanders Schmidler, Ph.D., of the Duke University School of Medicine in Durham, North Carolina, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #